Search research articles

Related Concept Videos

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Home
Extracellular Vesicle Analysis Allows For Identification Of Invasive Ipmn.

Home
Extracellular Vesicle Analysis Allows For Identification Of Invasive Ipmn.

Related Experiment Video

Author Spotlight: Peptidome Extraction from Small Extracellular Vesicles Isolated from Bone Marrow-Derived Macrophages

Author Spotlight: Peptidome Extraction from Small Extracellular Vesicles Isolated from Bone Marrow-Derived Macrophages

Published on: June 30, 2023

Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN.

Katherine S Yang¹, Debora Ciprani², Aileen O'Shea³

¹Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts.

Gastroenterology

|December 10, 2020

View abstract on PubMed

Summary

This summary is machine-generated.

MUC5AC protein in extracellular vesicles (EVs) from blood can accurately detect invasive pancreatic cancer in intraductal papillary mucinous neoplasms (IPMNs). This biomarker improves diagnostic accuracy, potentially preventing unnecessary surgeries for IPMN patients.

Keywords:

Early detection Exosome IPMN Pancreatic cancer Precancer

More Related Videos

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Published on: February 17, 2023

Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry

Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry

Published on: July 26, 2022

Related Experiment Videos

Author Spotlight: Peptidome Extraction from Small Extracellular Vesicles Isolated from Bone Marrow-Derived Macrophages

Author Spotlight: Peptidome Extraction from Small Extracellular Vesicles Isolated from Bone Marrow-Derived Macrophages

Published on: June 30, 2023

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines

Published on: February 17, 2023

Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry

Single Extracellular Vesicle Transmembrane Protein Characterization by Nano-Flow Cytometry

Published on: July 26, 2022

Area of Science:

Gastroenterology
Oncology
Biomarker Discovery

Background:

Intraductal papillary mucinous neoplasms (IPMNs) are increasingly detected, but distinguishing high-risk from indolent forms noninvasively remains challenging.
Current management strategies for IPMNs are controversial due to the lack of reliable methods for risk stratification.
Extracellular vesicle (EV) analysis offers a potential avenue for identifying malignancy markers in IPMNs.

Purpose of the Study:

To investigate the utility of extracellular vesicle (EV) protein biomarkers for differentiating high-risk IPMNs from indolent ones.
To identify specific EV-derived proteins in peripheral blood that can serve as noninvasive markers for IPMN malignancy.
To assess the potential of these biomarkers in improving patient management and surgical decision-making.

Main Methods:

A novel ultrasensitive digital extracellular vesicle screening technique (DEST) was employed to measure 23 putative malignancy biomarkers in EVs.
Circulating EVs were isolated from peripheral blood of 133 patients with IPMNs across two cohorts (discovery n=86, validation n=47).
Levels of EV proteins were correlated with IPMN histological grades, including high-grade dysplasia and invasive carcinoma.

Main Results:

MUC5AC was identified as a significantly elevated protein in EVs from high-grade IPMN lesions compared to lower-grade ones.
Plasma EV MUC5AC demonstrated high sensitivity (82%) and specificity (100%) in detecting invasive IPMN.
Combining MUC5AC with imaging and high-risk stigmata identified all surgically indicated cases, whereas conventional methods missed 36%.

Conclusions:

MUC5AC in circulating EVs is a promising noninvasive biomarker for predicting invasive carcinoma within IPMNs.
This EV-based approach can enhance the management and follow-up of IPMN patients.
The findings suggest a potential to reduce unnecessary surgical interventions by improving IPMN risk stratification.